Are you a Knight ADRC affiliated researcher with a news article you would like us to post?
Contact Us
Equity for African Americans in Alzheimer’s disease (Links to an external site)
For 20 years, the Knight Alzheimer Disease Research Center has worked to boost diversity in clinical trials.
Alzheimer’s Disease: Blood Test May Detect Condition 3 Years Before Clinical Diagnosis (Links to an external site)
Scientists say they have developed a test that can potentially detect Alzheimer’s disease a few years before people typically get a clinical diagnosis.
US approves Alzheimer’s drug that modestly slows disease (Links to an external site)
“This drug is not a cure. It doesn’t stop people from getting worse, but it does measurably slow the progression of the disease,” said Dr. Joy Snider, a neurologist at Washington University in St. Louis. “That might mean someone could have an extra six months to a year of being able to drive.”
Gut bacteria affect brain health, mouse study shows (Links to an external site)
Gut bacteria can influence brain health, according to a study of mice genetically predisposed to develop Alzheimer’s-like brain damage. The study, by researchers at Washington University School of Medicine in St. Louis, indicates that gut bacteria produce compounds that influence the behavior of immune cells, including ones in the brain that can cause neurodegeneration. The findings suggest a new approach to treating Alzheimer’s and other neurodegenerative diseases.
Dare We Say Consensus Achieved: Lecanemab Slows the Disease (Links to an external site)
Randall Bateman of Washington University, St. Louis, presented the biomarker evidence, concluding that it indicates the treatment modified underlying biology. “These findings support the ability to change the course of Alzheimer’s disease,” he told Alzforum.